In the days leading up to the meeting, Masimo said RTW more than tripled its ownership to 9.9%, causing its total ownership ...

Apple won the case, though was only awarded a nominal $250, which is the smallest amount it was possible for the court to order. In other words, yes Masimo did in infringe Apple’s patents, but there ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...

Apple and medical device company Masimo are currently embroiled in multiple legal battles, headlined by the ongoing fight over ...

Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...

Apple’s attorneys told the court the “ultimate purpose” of its lawsuit was to win an injunction against sales of Masimo’s smartwatches after an infringement ruling. The jury also ...

Piper Sandler raised the firm’s price target on Masimo (MASI) to $180 from $165 and keeps an Overweight rating on the shares. The firm notes the company announced Q3 revenue of $505M finished ...

Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have received an average rating of “Moderate Buy” from the seven ...

According to a regulatory filing, following a review by outside counsel, on October 24, 2024, the Board of Directors of Masimo (MASI) adopted ...

A federal jury ruled Friday that Masimo smartwatches infringed Apple patents, but Apple isn’t getting a big payday. Bloomberg Law reports that the company was only seeking the statutory minimum ...

The two lawsuits said Masimo copied Apple’s technology while seeking bans on sales and imports of Apple Watches in earlier ...